Morgan Stanley
SCNI

Morgan Stanley’s Scinai Immunotherapeutics SCNI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$581 Hold
255
﹤0.01% 7419
2025
Q1
$687 Hold
255
﹤0.01% 7334
2024
Q4
$853 Hold
255
﹤0.01% 7294
2024
Q3
$880 Hold
255
﹤0.01% 7238
2024
Q2
$709 Sell
255
-2,324
-90% -$6.46K ﹤0.01% 7193
2024
Q1
$1.34K Sell
2,579
-2,585
-50% -$1.34K ﹤0.01% 7138
2023
Q4
$3.08K Buy
5,164
+2,882
+126% +$1.72K ﹤0.01% 7079
2023
Q3
$1.99K Buy
2,282
+100
+5% +$87 ﹤0.01% 7133
2023
Q2
$3.08K Sell
2,182
-75
-3% -$106 ﹤0.01% 7096
2023
Q1
$4.88K Sell
2,257
-561
-20% -$1.21K ﹤0.01% 7055
2022
Q4
$8.34K Sell
2,818
-19,772
-88% -$58.5K ﹤0.01% 6997
2022
Q3
$17K Sell
22,590
-10,691
-32% -$8.05K ﹤0.01% 6864
2022
Q2
$39K Sell
33,281
-14,351
-30% -$16.8K ﹤0.01% 6715
2022
Q1
$79K Buy
47,632
+4,009
+9% +$6.65K ﹤0.01% 6464
2021
Q4
$103K Sell
43,623
-1,921
-4% -$4.54K ﹤0.01% 6420
2021
Q3
$100K Sell
45,544
-6,048
-12% -$13.3K ﹤0.01% 6379
2021
Q2
$148K Buy
51,592
+10,071
+24% +$28.9K ﹤0.01% 6168
2021
Q1
$157K Sell
41,521
-19,282
-32% -$72.9K ﹤0.01% 5793
2020
Q4
$171K Buy
60,803
+12,137
+25% +$34.1K ﹤0.01% 5668
2020
Q3
$1.9M Buy
48,666
+44,561
+1,086% +$1.74M ﹤0.01% 3696
2020
Q2
$94K Buy
4,105
+3,888
+1,792% +$89K ﹤0.01% 5432
2020
Q1
$2K Sell
217
-451
-68% -$4.16K ﹤0.01% 6399
2019
Q4
$6K Hold
668
﹤0.01% 6376
2019
Q3
$4K Sell
668
-3
-0.4% -$18 ﹤0.01% 6402
2019
Q2
$4K Buy
671
+149
+29% +$888 ﹤0.01% 6362
2019
Q1
$3K Buy
522
+52
+11% +$299 ﹤0.01% 6409
2018
Q4
$2K Buy
470
+10
+2% +$43 ﹤0.01% 6432
2018
Q3
$3K Hold
460
﹤0.01% 6517
2018
Q2
$3K Hold
460
﹤0.01% 6513
2018
Q1
$2K Sell
460
-1,125
-71% -$4.89K ﹤0.01% 6505
2017
Q4
$8K Buy
1,585
+1,076
+211% +$5.43K ﹤0.01% 6262
2017
Q3
$3K Buy
509
+312
+158% +$1.84K ﹤0.01% 6366
2017
Q2
$2K Buy
+197
New +$2K ﹤0.01% 6462
2016
Q2
Sell
-3
Closed 6635
2016
Q1
$0 Buy
3
+1
+50% ﹤0.01% 6690
2015
Q4
$0 Buy
+2
New ﹤0.01% 6775
2015
Q3
Sell
-3
Closed 6700
2015
Q2
$0 Buy
+3
New ﹤0.01% 6729